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Abstract
Necrotizing enterocolitis (NEC) is a leading cause of morbidity and mortality in neonatal intensive care units, however its
pathogenesis is not completely understood. We have previously shown that platelet activating factor (PAF), bacteria and
TLR4 are all important factors in the development of NEC. Given that Toll-like receptors (TLRs) are expressed at low levels in
enterocytes of the mature gastrointestinal tract, but were shown to be aberrantly over-expressed in enterocytes in
experimental NEC, we examined the regulation of TLR4 expression and signaling by PAF in intestinal epithelial cells using
human and mouse in vitro cell lines, and the ex vivo rat intestinal loop model. In intestinal epithelial cell (IEC) lines, PAF
stimulation yielded upregulation of both TLR4 mRNA and protein expression and led to increased IL-8 secretion following
stimulation with LPS (in an otherwise LPS minimally responsive cell line). PAF stimulation resulted in increased human TLR4
promoter activation in a dose dependent manner. Western blotting and immunohistochemical analysis showed PAF
induced STAT3 phosphorylation and nuclear translocation in IEC, and PAF-induced TLR4 expression was inhibited by STAT3
and NFkB Inhibitors. Our findings provide evidence for a mechanism by which PAF augments inflammation in the intestinal
epithelium through abnormal TLR4 upregulation, thereby contributing to the intestinal injury of NEC.
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Introduction
Necrotizing enterocolitis (NEC) is a devastating gastrointestinal
disease primarily affecting premature infants, and despite recent
advances in neonatal intensive care, it remains a leading cause of
morbidity and mortality in this high-risk population.
The etiology of NEC remains elusive, but inflammation is
thought to be central to its pathogenesis, leading to intestinal
injury and associated morbidities [1,2,3,4]. Previously, we and
others have shown that platelet activating factor plays a key role in
NEC in humans and in animals [5,6,7,8,9,10,11,12]. Platelet
activating factor (PAF) is a potent endogenous, extracellular and
intracellular phospholipid mediator, produced by a two-step
enzymatic process where phosphatidyl choline is the de novo
precursor and phospholipase A2 (PLA2-II) is the rate-limiting
enzyme. The secreted form of PLA2-II, responsible for the
extracellular production of PAF, is expressed by many cell types
including intestinal paneth cells and its release is triggered by
hypoxia, endotoxemia, and trauma among other stimuli. Activa-
tion of its G protein-coupled receptor, PAF-receptor (PAFR), leads
to activation of several signal transduction pathways including the
signal transducers and activators of transcription (STATs) and
NFkB [13], culminating in physiological or pathological changes
including vasoconstriction and/or vasodilatation, leukocyte stim-
ulation and migration, synthesis and activation of cell adhesion
molecules, increased capillary permeability, production of reactive
oxygen and nitrogen species, and alterations in intestinal mucosal
permeability [14,15].
In addition to PAF, the presence of enteric bacteria appears to
be a prerequisite for development of NEC [16]. Indeed, antibiotic
use has been shown to have a protective role in NEC in the rodent
model [17]. Enteric bacteria trigger Toll-like receptors (TLRs), a
family of transmembrane molecules that recognize specific
repetitive patterns associated with bacterial products [18], and
both bacteria and TLRs have been shown to be important for
experimental NEC pathogenesis [16,19]. However, we [20,21]
and others [22] have shown that the healthy, adult human
intestinal epithelium expresses low levels of TLR2 and TLR4,
which may serve to limit intestinal inflammation and injury in the
face of normal intraluminal bacterial exposure. On the other
hand, this low level expression is subject to regulation by some
inflammatory mediators (36).
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infection, or local injury, induces an upregulation of TLR4 at the
intestinal epithelium that predisposes to excessive bacterial
activation of the intestinal inflammatory response, leading to
intestinal necrosis and NEC. We have found that in various human
androdenttissueculturemodelsofintestinalepithelium,stimulation
withPAF results inan upregulationof TLR4 expression, correlating
with an enhanced TLR4 ligand-induced inflammatory gene
expression. Furthermore, in cells over-expressing PAFR, treatment
with PAF resulted in a dose-dependent activation of a TLR4
promoter reporter construct, and in an in vivo model, luminal
perfusion of an ileal loop with PAF resulted in enhanced intestinal
TLR4 gene expression. PAF caused a translocation of STAT3 from
the cytosol to the nuclei of enterocytes and the PAF-induced
induction of TLR4 expression was inhibited by pharmacological
inhibition of the STAT3 and NFkB signaling pathways.
Materials and Methods
Ethics Statement
All experiments were performed according to the guidelines and
approved protocol (IACUC approval ID #EH05-026) of the
NorthShore University HealthSystem Institutional Animal Care
and Use Committee and were housed under specific pathogen free
conditions.
Reagents and Inhibitors
Carbamyl PAF C-16 (cPAF) (Alexis Biochemicals, San Diego,
CA), dissolved in ethanol, was used in stimulation of cells. Highly
purified, phenol-water-extracted Escherichia coli K235 LPS (,0.008%
protein) was prepared according to the method of McIntire et al.
[23] and obtained from S. N. Vogel (Uniformed Services University
of the Health Sciences, Bethesda, MD) [24,25]. The purity of this
LPS has been demonstrated previously [26,27]. The following
inhibitors were used to pretreat IEC-6 cells for 30 minutes prior to
and throughout PAF stimulation (all from Calbiochem/EMD
Biosciences, San Diego, CA): BAY 11–7082 to inhibit nuclear
translocation of NFkB, Proteasome Inhibitor II (PS I–II), Tyro-
phostin AG490 protein kinase inhibitor that selectively inhibits
activation of STAT3.
Cell culture
Human embryonic kidney cells (HEK293), COS-7 cells, human
intestinal epithelial Caco-2 and rat small intestine epithelial cell
line IEC-6 were obtained from the American Type Culture
Collection (ATCC, Manassas, VA), and were grown as recom-
mended by ATCC. The HT29-CL19A, differentiated colonocyte
cell line was a generous gift from C.L. Laboisse (Cleveland, OH)
[28] and were maintained in DMEM with 10% FBS, 2% Pen/
Strep. For experiments that required transfection, cells were set up
at 30% confluence and were transfected using Lipofectamine 2000
according to the manufacturer’s instructions.
Intraluminal perfusion of PAF in isolated ileal loop
Following 24 hrs of fasting (water only), juvenile rats (approx
150 g body weight) were anesthetized with Nembutal. Following
cannulation of the left jugular vein, the right carotid artery, and
the trachea, a midline abdominal incision was made. The cecum
was brought to the surface and PE-50 tubing was secured into
ileum just proximal to the cecum. Following inflation of the
intestine with 2 ml saline (vehicle) or 2 ml PAF at various doses,
the intestine was lowered in the abdominal cavity, and the
abdominal wall was closed around the PE tubing. While
maintaining anesthesia, the intestine was perfused for 4–6 hrs
with saline, or saline + PAF etc. at a rate of 1 ml/h. Hematocrit
was measured every 30 minutes. At the termination of the
experiment animals were euthanized with pentobarbital, intestines
are collected and split in half lengthwise, half for frozen sectioning
and the other half for RNA isolation.
Construct propagation and purification
ThehumanTLR4promoter-luciferasecDNAwasakindgiftfrom
M. Rehli (Regensburg, Germany), preparation previously described
[29]. pCMV-b-galactosidase were used as previously described [20].
Human platelet activating factor receptor (PAFR) adenoviral vectors
were constructed using the AdEasy system (Stratagene, La Jolla,
CA) as recommended by the manufacturer. Viruses were purified
through serial CsCl density gradient centrifugations and subsequent
dialysis. Viral titers were quantified by infecting HEK293 cells with
serial dilutions of the virus. All viral preparations were screened for
Endotoxin contaminations (Endosafe, Charles River Laboratories,
MA). Additionally, cDNA corresponding to tagged wild type human
PAFR was subcloned downstream from a human immediate-early
CMV promoter-enhancer element into the pCDNA 3.1/GS vector
(Invitrogen, Carlsbad, CA).
Transient gene expression and reporter gene assays
HEK293 cells were co-transfected with CMV-b-galactosidase
(0.075 mg), PAFR constructs (0.2 mg), and human TLR4 promot-
er-luciferase (0.05 mg) using FuGENE 6 transfection reagent
(Roche, Basel, Switzerland) as per the manufacturer’s instructions
in 24 well plates. After overnight transfection, cells were stimulated
for 5 h with cPAF (0–150 nM, as indicated), and luciferase activity
was measured with a luciferase kit (Promega, Madison, WI) as
described previously [30]. Transfection efficiency was normalized
by assaying for b-galactosidase activity using a colorimetric
method (Stratagene, La Jolla, CA) as previously described [30].
Quantitative real time PCR
Transcript levels weredetermined using QRT-PCR normalized to
GAPDH. Primers and probes used: rat GAPDH-VIC, human
GAPDH-VIC (both primers limited) with rat and human TLR4-6-
FAM primer and probe sets (Applied Biosystems, Foster City, CA).
IEC-6 cell RNA was isolated using RNA STAT-60 (Tel-Test Inc,
Friendswood, TX) and from Caco-2 cells using RNeasy columns
(Qiagen, Valencia, CA). RNA was quantified and integrity was
verified by agarose gel electrophoresis. cDNA was prepared by
reverse transcription from 1 mg of IEC-6 of RNA and 25 ng of Caco-
2R N A .F o rq u a n t i fi c a t i o no fT L R 4i nI E C- 6 ,e a c h2 5mlQ R T -P C R
reaction contained 1 ml of cDNA, 900 nM each primer, 250 nM
probe universal PCR master mix (Applied Biosystems, Foster City,
CA). These QRT-PCR reactions were preformed in a Smartcycler
( C e p h e i d ,S u n n y v a l e ,C A ) .F o rC a c o - 2c e l l s ,e a c h1 0mlQ R T - P C R
reaction contained 0.5 ml cDNA, 900 nM primer, 250 nM probe
(both GAPDH and TLR4 probes in a duplex reaction) and Jump
Start TAQ Ready Mix PCR master mix (Sigma, St, Louis MO)
according to manufacturer’s suggested methods. These QRT-PCR
were performed in a Rotor Gene machine (Corbett Life Science,
Sydney, Australia). Each primer and probe set was initially analyzed
and found to have a linear relationship between 2
2CT,a n dt h e
dilution factor for all reactions showed CT values ,38.
Nuclear and cytoplasmic fraction preparation and
western blotting
IEC-6 cells were grown to confluence in 10 cm Petri dishes and
were treated with or without cPAF as indicated. Cells were
harvested and nuclear and cytoplasmic fractions were prepared
PAF Induces TLR4 in Intestinal Epithelial Cells
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Samples were subjected to SDS-PAGE and transferred to PVDF
membrane, blocked with 5%non-fat milkinTBST-0.1%Tween 20
and incubated with mouse monoclonal antibodies against STAT3
(Invitrogen/Zymed, Carlsbad, CA) followed by horseradish perox-
idase-conjugated anti-mouse IgG (Santa Cruz Biotechnology, Santa
Cruz, CA), or were incubated with a rabbit polyclonal antibody to
STAT3 pY705, (Biomol, Plymouth Meeting, PA), followed by
incubation with horseradish peroxidase-conjugated anti-rabbit IgG
(Santa Cruz Biotechnology, CA). Blots were visualized using
enhanced chemiluminescence detection solution (Amersham Phar-
macia Biotech, Piscataway, NJ) and scanned with a Phosphor
Imager (Molecular Dynamics; Piscataway, NJ).
Immunocytochemistry
For immunocytochemistry analysis, IEC-6, COS-7 or HT29-
CL19A cells were seeded onto glass coverslips. COS-7 cells were
exposed to AD-PAFR (10
9 viral particles/10
6 cells) for 24 hrs. All
cells were treated with cPAF or vehicle as indicated. COS-7 cells
were fixed in 4% paraformaldehyde, all other cells were fixed in
100% methanol at 220uC, and all cells permeabilized with 0.1%
Triton X-100 in PBS. Following washing and blocking, cells were
probed with mouse monoclonal anti-STAT3 (diluted 1:50 in 10%
goat serum) (Invitrogen/Molecular Probes, Carlsbad, CA) over-
night at 4uC in a humidified chamber followed by incubation with
Alexa Fluor 546 labeled goat anti-mouse secondary antibody for
1 h at 37uC in a humidified chamber. Coverslips were mounted
onto glass slides in anti-fade mounting medium (Molecular Probes)
and observed by fluorescence microscopy.
Image analysis and display
Specimens were viewed using a Leica microscope equipped with
epifluorescence illumination and appropriate fluorescence filters for
DAPI, Alexa Fluor 488/GFP and Alexa Fluor 546. Fluorescence
images in each wavelength were collected using a Coolsnap CCD
camera and were relayed to the IPLab Spectrum image analysis
software. Images from the control and experimental groups were
subjected to identical grayscale normalization and contrast
enhancement and were then subjected to pseudocolor overlay to
produce the color images.
ELISA
For human IL-8 detection, 50,000 Caco-2 cells were plated per
well in 96-well plates. Cells were treated with cPAF (5 mM) for
24 h, then washed with PBS and stimulated with LPS (10 ng/ml)
overnight. The supernatants were harvested for measurement of
IL-8 using IL-8 ELISA Kit (R&D Systems, Minneapolis, MN) as
per the manufacturer’s instructions.
Statistical Analysis
Data are reported as mean values 6S.D of three or more
independent experiments. The statistical significance of differences
between mean values was determined by Student’s t test, unless
otherwise indicated. Student’s t tests, standard deviation, and
standard errors were performed using the statistics package within
Microsoft Excel. A pvalueoflessthan0.05wasconsideredsignificant.
Results
Platelet-activating factor induces TLR4 expression in the
rat intestinal mucosa
TLR4 expression is very low in the mature, healthy intestinal
mucosa and has been shown to be regulated by inflammatory
cytokines. Our earlier studies have shown that in rodent models of
necrotizing enterocolitis where PAF plays an important role,
TLR4 expression is aberrantly elevated in the intestinal epitheli-
um, implicating PAF in the regulation of TLR4 expression. In
order to test whether PAF can regulate TLR4 expression, we
developed a perfused ileal loop model, where the effect of
intraluminal perfusion of PAF on gene expression can be directly
evaluated. In this model, perfusion of PAF in the lumen of the
ileum resulted in an increase of TLR4 expression in mucosal
scrapings that was not observed either in the mucosa of sham-
perfused animals, or in the mucosa outside of the perfused loop
either in the PAF-perfused or sham perfused animals (Figure 1).
Platelet-activating factor induces TLR4 mRNA expression
and promotes IL-8 secretion in intestinal epithelial cells
To determine if PAF can regulate TLR4 expression specifically
in epithelial cells, two experimental models were utilized. As NEC
occurs more frequently in the small intestine, a murine small
intestinal epithelial cell line, IEC-6, was used as our primary
model. Following stimulation of cells with cPAF, we observed a
dose- and time-dependent increase in TLR4 gene expression using
Real Time PCR analysis (Figure 2a and b). To corroborate these
results and demonstrate similar findings in human derived cells,
our second experimental model utilized the Caco-2 colon cancer
line. Human IEC lines recapitulate many features of normal IEC
and can be used to simulate the ability of IEC to respond to
pathogen associated molecular patterns (PAMPs). Several IEC
lines, including the Caco-2 cell line, respond minimally to LPS
because of very low TLR4 expression [20,22,31]. Six hours post
stimulation with cPAF, we observed a subsequent dose-dependent
Figure 1. Induction of TLR4 expression by intraluminal PAF.
Adult rat ileal loops were perfused with saline (sham), or with saline
+10 mM carbamyl PAF for 4 hrs as indicated. Total RNA was isolated
from mucosal scrapings and QRT-PCR was performed to quantify TLR4
and GAPDH mRNA copy numbers. TLR4 mRNA level is shown as %
GAPDH. L indicates ileal loop mucosa, NL indicates non loop mucosa.
TLR4 mRNA was significantly increased only in the mucosa that was in
direct contact with PAF. * p,0.05.
doi:10.1371/journal.pone.0015044.g001
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analysis (Figure 2c). We addressed the functionality of the induced
TLR4 by exposing these cells to LPS. We found increased IL-8
secretion by Caco-2 cells exposed to 5 mM PAF for 24 h, then
stimulated for 18 h with 10 ng/ml LPS as measured by ELISA. In
contrast, no increase in IL-8 secretion occurred when Caco-2 cells
were treated with either PAF or LPS alone (Figure 3). These
results indicate that LPS could stimulate IEC secretion of IL-8, but
only if TLR4 expression was first induced by treating the cells with
PAF and later stimulated with TLR4 ligand.
Interestingly, the rat (IEC-6, Fig. 2b) and human (Caco-2,
Fig. 2c) cell lines used possessed very different dose responses to
PAF. IEC-6 cells undergo apoptosis at higher than 2 mM PAF
concentrations, thus making it difficult to impossible to measure
gene expression at those conditions. Additionally, the baseline
TLR4 expression is significantly higher in IEC-6. Nevertheless,
TLR4 expression in both cell lines is subject to regulation by PAF.
Platelet-activating factor increases TLR4 protein
expression in intestinal epithelial cells
To determine whether or not the increased mRNA of IEC
following PAF stimulation leads to a corresponding increase in
TLR4 protein expression, immunohistochemistry was performed.
Due to extremely low expression levels in Caco-2 cells, we could
not detect TLR4 and commercially available antibodies did not
detect rat TLR4 in IEC-6. Upon testing various cell lines, we have
found that human TLR4 is readily detected in HT29-CL19A cells.
Therefore, HT29-CL19A cells were treated with or without PAF
and probed with anti-TLR4 antibodies. As seen in Figure 4, there
appeared to be increased TLR4 expression in cells treated with
PAF as compared to unstimulated control. These data suggest that
although TLR4 is weakly expressed on the surface of IEC, platelet
activating factor stimulation upregulates expression of the
receptor. This could potentially result in increased recognition of
TLR4 ligands at the intestinal epithelial surface and subsequently
lead to production of inflammatory cytokines.
Platelet-activating factor induces TLR4 promoter
activation
The PAF-induced changes in TLR4 mRNA and protein levels
could be due to regulation of transcription or could be a result of
posttranscriptional mechanisms. In order to determine whether
stimulation with PAF can affect TLR4 promoter activation, we
first transiently transfected HEK293 cells (which express negligible
endogenous PAFR and TLR4) with a TLR4 promoter-luciferase
reporter construct and PAFR cDNA. Upon stimulation with PAF,
a significant dose-dependent four-fold increase in TLR4 promoter
activity (compared to unstimulated empty vector control) was
observed (Figure 5). Doses of PAF above 200 nM were toxic to
HEK 293 cells. Control diluents at the different concentrations of
PAF did not induce any luciferase activity (data not shown).
Platelet-activating factor induces STAT3 phosphorylation
and nuclear translocation in intestinal epithelial cells
To begin addressing the possible signaling mechanisms that may
underlie PAF-mediated regulation of TLR expression, we
evaluated the potential roles of two major transcription factors
regulated by PAF, STAT3 [32] and NF-kB [33], both of which
have been implicated in TLR4 signaling and/or gene expression
regulation [34]. We first wished to verify that PAF stimulation
activated STAT3 in IEC, as was shown before in COS-7 cells. We,
therefore, performed immunohistochemistry using anti-STAT3 on
IEC-6 cells and COS-7 cells (which express very low levels of
Figure 2. PAF-induced TLR4 expression in intestinal epithelial cells. IEC-6 (a and b) and Caco-2 (c) cells were grown in Petri dishes and
treated with increasing concentrations of cPAF for for the indicated periods of time (a) or 6 h with 2 mM cPAF (b and c). cDNA copy numbers for TLR4
and GAPDH were quantified using QRT-PCR and TLR4 mRNA levels were expressed as %GAPDH. Treatment with PAF resulted in a dose- and time-
dependent increase of TLR4 mRNA. * p,0.01 vs. untreated controls.
doi:10.1371/journal.pone.0015044.g002
Figure 3. PAF increases IL-8 in intestinal epithelial cells with
TLR4 ligand stimulation. Human IEC (Caco-2) were exposed to PAF
5 mM for 24 h, then stimulated for 18 h with 10 ng/ml LPS.
Supernatants were harvested for IL-8 measurement by ELISA. Treatment
with PAF caused a priming effect, resulting in LPS-induced IL-8
secretion by Caco-2. * p,0.05 compared to either untreated control,
LPS or PAF alone.
doi:10.1371/journal.pone.0015044.g003
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PAF stimulation for 1 h, nuclear translocation of STAT3 was
observed in both cell lines compared with unstimulated controls
(Figure 6 a–j). To further demonstrate the effects of PAF on
STAT3 in intestinal epithelial cells, STAT3 and phospho-STAT3
Western blots were performed on cytoplasmic and nuclear
fractions of IEC-6 cells, following PAF stimulation. As anticipated,
we observed an increase in phospho-STAT3 in the nuclear
fraction following PAF stimulation but not in the unstimulated
control nuclear fraction (Figure 6k). These results indicate that
stimulation with PAF activates STAT3, a transcription factor that
may be involved in TLR4 transcriptional regulation.
Platelet-activating factor induced TLR4 expression is
inhibited by STAT3 and NFkB inhibitors
To further address the potential mechanism of PAF-induced
TLR4 upregulation, we pretreated IEC-6 cells with inhibitors of
STAT3 and NF-kB activation, then treated the cells with PAF
(2 mM 4 h), followed by QRT-PCR analysis of TLR4 expression.
There was a significant reduction in TLR4 mRNA expression
following PAF stimulation in those cells pretreated with Tyrphos-
tin AG490 (an indirect STAT3 inhibitor, via JAK2 inhibition),
Bay 11–7082 (an inhibitor of NFkB activation via inhibition of IkB
phosphorylation), or PSI-II (an inhibitor of NFkB activation via
proteasome inhibition) as compared to PAF stimulation alone
(Figure 7), while DMSO, the vehicle for this compound had no
effect on PAF-induced TLR4 expression. These data suggest that
activation of both STAT3 and NFkB are likely involved in PAF-
induced upregulation of TLR4 expression in IECs.
Discussion
Platelet activating factor plays an important role in the initiation
and/or maintenance of mucosal inflammation and intestinal
injury [10]. Although PAF has been implicated in numerous
diseases involving mucosal inflammation, such as asthma [35,36],
peptic ulcer[37], Crohn’s disease [38], and ulcerative colitis [39],
its pathogenic role is best established in neonatal necrotizing
enterocolitis (NEC). We have shown that PAFR inhibition reduced
the risk of NEC in a neonatal animal model using clinical risk
factors for NEC (bacterial colonization, intestinal ischemia, and
formula feeding) [5]. We have also shown that giving the PAF-
degrading enzyme PAF-acetylhydrolase (PAF-AH) with enteral
feedings prevents the initiation of experimental NEC in this rat
model [7]. The intestine, particularly the distal small bowel, is at
increased risk for PAF-induced inflammatory injury, since PAF-
receptor gene is constitutively expressed at the highest level in the
ileum compared to other organs [40]. Our previous studies have
shown that the development of NEC in a rodent model is preceded
and underlined by exaggerated enterocyte apoptosis [41] and that
PAF is a potent inducer of enterocyte apoptosis in tissue culture
[42]. However, while the role of PAF has been established in this
NEC neonatal rat model, the mechanisms by which PAF
contributes to NEC are not completely understood.
TLRs are important in the protection of the host. They initiate
the innate immune response modulate the adaptive immune
Figure 4. PAF induces TLR4 expression in intestinal epithelial cells. Human IEC (HT29-Cl19A cells) were grown on glass coverslips and
treated without or with cPAF 5 mM for 24 h. Expression of TLR4 (shown in red) was detected using immunofluorescent microscopy (DAPI is blue).
Treatment with PAF resulted in an apparently enhanced TLR4 immunoreactivity on the surface of HT29-Cl19A cells. When non-immune serum was
used in place of the TLR4 antibody there was no staining detected above background (not shown).
doi:10.1371/journal.pone.0015044.g004
Figure 5. PAF induces TLR4 promoter activation. HEK293 cells
transiently transfected with PAFR, human TLR4 promoter-luciferase and
b-galactosidase cDNA were stimulated with cPAF (0–150 nM) for 5 h or
empthy vector control. TLR4 promoter luciferase activity was measured
with luciferase assay and normalized with b-gal activity. The data are
expressed as fold induction of relative light units when compared with
transfection of unstimulated controls. This data is representative
experiment of three independent experiments performed in triplicate
and y-error bars indicate SD. *p,0.05 compared to untreated control.
doi:10.1371/journal.pone.0015044.g005
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derive either from bacteria, viruses or fungi and initiate signaling
that results in expression and release of inflammatory cytokines.
We and others [20,22,34,43,44] have shown that IEC of the
mature, healthy small and large intestine express low levels of
TLR4 and MD-2 and respond poorly to LPS, but TLR4 and MD-
2 are abnormally upregulated in inflammatory bowel disease [34].
The very low level of expression of and subdued signaling via
TLRs may represent an adaptation of IEC to prevent collateral
tissue damage from an unnecessary inflammatory response to
commensal organisms. Ongoing signaling between commensals
and TLRs has an important beneficial effect on the maintenance
of normal barriers in the intestine and enhances protection and
repair from injury [45]. We have also demonstrated in an animal
model of acute colitis using dextran sulfate sodium that TLR4,
through the adapter protein MyD88, is important in the intestinal
response to epithelial injury and limiting bacterial translocation
[46]. We know that TLRs are expressed on fetal enterocytes [47].
More directly, we have recently shown in an established neonatal
rat model and a novel neonatal murine model of NEC, that
bacteria and TLR4 play a significant role in experimental NEC,
likely via an interaction of intraluminal bacteria and aberrantly
overexpressed TLR4 in enterocytes [16].
Our current study sought to provide a link between PAF and
TLR4 expression in explaining how their interaction could shed
light on the pathogenesis of NEC. We found that PAF is able to
upregulate the normally low TLR4 expression in rat intestinal
epithelium in vivo and in both human and rat IEC in tissue culture.
Furthermore, priming with PAF directly led to enhanced LPS-
induced IL-8 secretion, thus showing the functional effect of
increased TLR4 expression. Whether the priming effect of PAF on
LPS-induced IL-8 secretion can be explained solely by the PAF-
induced higher level TLR4 expression or whether PAF also had an
effect on TLR4 signaling is yet to be determined.
We show that perfusion of PAF in the lumen of the ileum in this
experimental model results in an increase of TLR4 expression in
mucosal scrapings that is not seen either in the mucosa of sham-
perfused animals or in the mucosa outside of the perfused loop
either in the PAF-perfused or sham perfused animals. These
observations imply that luminal exposure of PAF can lead to
changes in TLR4 expression and signaling. Indeed, several studies
have shown that in this rodent model of NEC PAF levels as well as
PAF-synthesizing enzyme PLA2 are increased in tissue homoge-
nates and are secreted into the lumen [10]. Furthermore, in the
human preterm infant with NEC, luminal stool levels of PAF are
increased compared to those without NEC [48].
Our findings provide initial mechanistic explanations for PAF-
induced TLR4 expression. TLR4 expression may be primarily
due to PAF, or to a downstream molecule released in response
to PAF. In trying to further define the potential cascade initiated
by PAF-induced TLR4 expression, we focused on the roles
of two transcription factors, STAT3 and NF-kB. Consistent with
Figure 6. PAF-induced STAT3 translocation to nuclei in IEC-6 cells and in COS-7 cells transfected with the human PAFR. IEC-6 cells
were treated without (a,b,c), or with (d,e,f) 2 mM PAF for 1 h then fixed and processed for STAT3 immunohistochemistry (a,d; c and f red) and nuclei
were counterstained with Hoechst dye (b,e; c and f blue). COS-7 cells were first incubated with AD-PAFR for 24 hrs then without (g,h), or with (i,j)
1 mM PAF for 1 h. Triple label immunohistochemistry was performed with anti STAT3 (red), anti PAFR (green) and the DNA binding dye Hoechst
(blue). Rat small intestinal cells (IEC-6) were treated as indicated, then Western blots were performed on cytoplasmic and nuclear fractions using
antibodies against STAT3 and phorphorylated STAT3 (p-STAT3).
doi:10.1371/journal.pone.0015044.g006
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phosphorylation and nuclear translocation of STATs [32,49,50],
we demonstrated that STAT3 is phosphorylated upon PAF
stimulation in intestinal epithelial cells, and that this leads to
nuclear translocation. Although the TLR4 promoter region has no
direct STAT3 binding site, its PU.1 binding site is considered to be
one of its main regulatory elements and STAT3 has been shown to
be capable of activating PU.1 [51]. It is also likely that TLR4
upregulation reflect a secondary effect of a downstream STAT3
product. NF-kB is both a downstream effector of TLR signaling
and it is an upstream regulator of TLR4 expression, making this
transcription factor a central molecule in inflammatory regulation.
PAF has been shown to activate NF-kB in enterocytes in vivo [52]
and in several other cell types in tissue culture [33,53]. In light of
PAF’s ability to activate NF-kB and given that the TLR4
promoter contains NF-kB binding sites [29], it is not surprising
that we observed a dependence of PAF-induced TLR4 gene
expression on NF-kB activation. Future experiments will elucidate
the exact mechanisms of STAT3 involvement, and possibly other
factors, in PAF mediated transcriptional activation of TLR4 and
will investigate experimental models where PAF is neutralized.
In summary, PAF has been recognized to play an important
role in the development of the intestinal inflammatory injury seen
in NEC. Bacteria have also been implicated in the pathogenesis of
neonatal NEC, and the activation of abnormally expressed TLRs
at the intestinal epithelium is central to this process. Results here
suggest that one possible link between these is that PAF stimulation
triggers dysfunctional innate immune signaling that over-reacts to
bacterial ligands from gut commensals, and thus leads to
inflammation and associated collateral tissue damage. Our studies
thus contribute to our understanding of how the intestinal
epithelium participates in the innate immune response to PAF
and bacterial ligands in neonatal NEC, and opens the door for
future experimental studies and possibly even targeted therapies to
limit disease, or perhaps even to prevent NEC in at risk patients.
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